Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01579929
Title Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Cancer Center Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Cancer Center at Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre New York 11570 United States Details
Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow New York United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field